2Genest JJr,McNamara JR,Ordoras JM, et al, Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease, Am J Cardiol, 1991,67 : 1039-1045.
3Lipid Research Clinics Coronary Prevention Trial: I. Reduction in incidence of coronary heart disease. JAMA,1984,251:351-364.
4Soma MR,Osnago-Gadda I,Paoletti R,et al . The lowing of lipoprotein (a) induced by estrogen plus progesterone replacement therapy in postmenopausal women. Arch Intern Med, 1993,153: 1462-1468.
5Swislocki A. Insulin resistance and hypertension. Am J Med Sci, 1990,300 : 104-115.
6Wolfe BM,Huff MW, Effects of continuous low-dosage hormonal replacement therapy on lipopretein metabolism in postmenopausal women. Metabolism, 1995, 40: 410-417.
7Wenger NK, Postmenopausal hormone use for cardioproteetion:what we know and what we must learn. Curr Opin Cardiol, 1999,14 : 292-297.
